Pulmonary Hypertension, Primary, 1
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
9
|
323
|
0.400 |
None |
|
0 |
1
|
|
|
Pulmonary Hypertension, Primary, Fenfluramine-Associated
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
|
0.300 |
None |
|
0 |
|
|
|
PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
3
|
0.300 |
None |
|
0 |
|
|
|
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
1
|
0.300 |
None |
|
0 |
|
|
|
Increased pulmonary vascular resistance
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Cerebrovascular accident
|
group |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1658
|
591
|
0.400 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
2-oxo-hept-3-ene-1,7-dioate hydratase activity
|
phenotype |
|
Molecular Function
|
14
|
|
0.300 |
strong |
1.000 |
1 |
|
2017 |
2017 |
Acute Cerebrovascular Accidents
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
155
|
2
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Astrocytosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
37
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Pulmonary Hypertension
|
phenotype |
Respiratory Tract Diseases
|
Pathologic Function
|
156
|
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Gliosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
102
|
3
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Status Epilepticus
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
533
|
12
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Deafness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Finding
|
62
|
37
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Systolic blood pressure measurement
|
phenotype |
|
Diagnostic Procedure
|
54
|
95
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Alcohol consumption
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
210
|
535
|
0.100 |
None |
1.000 |
1 |
3
|
2018 |
2018 |
Diverticular Diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
83
|
88
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Ischemic stroke
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1159
|
704
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Potassium measurement
|
phenotype |
|
Laboratory Procedure
|
16
|
28
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Tuberculosis, Drug-Resistant
|
disease |
Infections
|
Disease or Syndrome
|
37
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Multiple Chronic Conditions
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
929
|
42
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Disorder of pulmonary circulation
|
group |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Right Ventricular Hypertrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
160
|
6
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2438
|
563
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hypocholesterolemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
113
|
22
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Ventricular Fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
96
|
19
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |